Gene · 6716
Papers1,787
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,787
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance. | Int J Mol Sci | 2022 | 36362304 | PubTator, text mining | PubMed |
| Rare and common genetic determinants of metabolic individuality and their effects on human health. | Nat Med | 2022 | 36357675 | PubTator, text mining | PubMed |
| Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia. | BMC Urol | 2022 | 36344974 | PubTator, text mining | PubMed |
| Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma. | Front Oncol | 2022 | 36338737 | PubTator, text mining | PubMed |
| In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications. | Biomaterials | 2022 | 36334354 | PubTator, text mining | PubMed |
| Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy. | Front Oncol | 2022 | 36324578 | PubTator, text mining | PubMed |
| Neurofibromatosis Type 1 and Hypospadias in a Male 46, XY with a Mutation in the NF1 Gene and a Mutation in NR5A1. | Pharmgenomics Pers Med | 2022 | 36317063 | PubTator, text mining | PubMed |
| Review of prostate cancer genomic studies in Africa. | Front Genet | 2022 | 36303548 | PubTator, text mining | PubMed |
| Preclinical and Clinical Research Models of Prostate Cancer: A Brief Overview. | Life (Basel) | 2022 | 36295041 | PubTator, text mining | PubMed |
| Mechanisms of action of Zishen Yutai pills in treating premature ovarian failure determined by integrating UHPLC-Q-TOF-MS and network pharmacology analysis. | BMC Complement Med Ther | 2022 | 36289509 | PubTator, text mining | PubMed |
| Cytogenetic and molecular insight into the genetic background of disorders of sex development in seventeen cats. | Sci Rep | 2022 | 36280698 | PubTator, text mining | PubMed |
| Less-Invasive Diagnostic Approaches for Infants with Suspected Differences of Sex Development: A Case Report of a 297-g Neonate with Ambiguous Genitalia. | Neonatology | 2022 | 36273444 | PubTator, text mining | PubMed |
| Disorders of sex development (DSD) 46.XY due to type 2 5-α reductase deficiency in three siblings: Case report from a low-resource setting. | Ann Med Surg (Lond) | 2022 | 36268297 | PubTator, text mining | PubMed |
| A literature perspective on the pharmacological applications of yohimbine. | Ann Med | 2022 | 36263866 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing technology demonstrates the heterogeneity between aged prostate peripheral and transitional zone. | Clin Transl Med | 2022 | 36245324 | PubTator, text mining | PubMed |
| A comprehensive transcriptomic comparison of hepatocyte model systems improves selection of models for experimental use. | Commun Biol | 2022 | 36241695 | PubTator, text mining | PubMed |
| Camellia Seed Cake Extract Supports Hair Growth by Abrogating the Effect of Dihydrotestosterone in Cultured Human Dermal Papilla Cells. | Molecules | 2022 | 36234980 | PubTator, text mining | PubMed |
| SurviveAI: Long Term Survival Prediction of Cancer Patients Based on Somatic RNA-Seq Expression. | Cancer Inform | 2022 | 36225330 | PubTator, text mining | PubMed |
| Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study. | Ann Dermatol | 2022 | 36198626 | PubTator, text mining | PubMed |
| The Hair Growth-Promoting Effect of Gardenia florida Fruit Extract and Its Molecular Regulation. | Evid Based Complement Alternat Med | 2022 | 36193135 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6716/papers?page=14